Evaluation of Patients on Thyroxine (T4) Replacement with a Highly Sensitive Commercial TSH Immunoradiometric Assay (TSH-IRMA)
Current strategies for the optimal management of patients requiring thyroid hormone replacement or suppression therapy are limited by the nonspecificity and insensitivity of clinical symptoms and by the impracticality of frequent or extensive laboratory evaluation of thyroid status (e.g., TSH testing, radioiodine uptake). The recent introduction of highly sensitive TSH assays which distinguish suppressed from normal TSH levels offers a practical means for applying more precise assessment of basal TSH secretion. This study was conducted to illustrate the potential for under- or over-medication of patients receiving T4 replacement or T4 suppression when managed conventionally and to suggest a practical strategy for improved management employing sensitive TSH measurement.
KeywordsRadioiodine Uptake Alter Thyroid Hormone High Sensitivity Serum Thyroid Hormone Binding Protein
Unable to display preview. Download preview PDF.
- 3.Alexander WD, Kerr DJ, and Ferguson MM. Lancet ii: 647, 1984.Google Scholar